The results presented in this report support these findings, and importantly, demonstrate that ARC regulates leukemia/stromal interactions likely via several NFκB/IL1β-mediated receptor/chemokine axes that seem to further support AML cell chemoresistance. Here, IL1B is linked to leukemia.